mRNA-4157,Pembrolizumab
merck,moderna
['melanoma', 'melsm', 'pembro']
personalized mrna-based cancer vaccine plus pembrolizumab for high-risk melanoma #immunotherapy #cancer #vaccine #melsm #melanoma #oncology #aacr23 
News and views from the world of clinical oncology and hematology